Cargando…

Combined Intravenous Urogram and 68Ga-PSMA PET/ CT for Improved Staging and Restaging of Prostate Cancer

Staging/restaging of prostate cancer utilizing Gallium-68 ((68)Ga) prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in combination with an intravenous urogram allows improved discrimination between radiotracer activity in the renal tract and small p...

Descripción completa

Detalles Bibliográficos
Autores principales:	McBean, Rhiannon, Kumari, Anisa, McEwan, Louise, Walters, James, Wong, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Scientific Scholar 2020
Materias:	Pictorial Essay
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656033/ https://www.ncbi.nlm.nih.gov/pubmed/33194309 http://dx.doi.org/10.25259/JCIS_88_2020

Ejemplares similares

Musculoskeletal pitfalls in (68)Ga-PSMA PET/CT
por: Pontes, Írline Cordeiro de Macedo, et al.
Publicado: (2023)

Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
por: Barakat, Andrew, et al.
Publicado: (2020)

Comparison of [(18)F]PSMA-1007 with [(68)Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Dual-Time Point [(68)Ga]Ga-PSMA-11 PET/CT Hybrid Imaging for Staging and Restaging of Prostate Cancer
por: Hoffmann, Manuela A., et al.
Publicado: (2020)

Nonspecific Uptake of (68)Ga-Prostate-Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature
por: Malik, Dharmender, et al.
Publicado: (2018)

Restaging the Biochemical Recurrence of Prostate Cancer with [(68)Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
por: Fourquet, Aloÿse, et al.
Publicado: (2021)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

The Role of PET/CT for Evaluating Breast Cancer
por: Yang, Sang Kyu, et al.
Publicado: (2007)

Pitfalls and artifacts in the interpretation of oncologic PET/CT of the chest
por: Meirelles, Gustavo de Souza Portes, et al.
Publicado: (2017)

False Positive and False Negative FDG-PET Scans in Various Thoracic Diseases
por: Chang, Jung Min, et al.
Publicado: (2006)

Incidentally Detected Mediastinal Vascular Anatomical Variants on PET-CT: A Pictorial Essay
por: Paidipati, Kathyayini Gopalkrishna Murthy, et al.
Publicado: (2015)

FDG-PET/CT for diagnosis of cyst infection in autosomal dominant polycystic kidney disease
por: Pijl, J. P., et al.
Publicado: (2018)

Atlas of non-pathological solitary or asymmetrical skeletal muscle uptake in [(18)F]FDG-PET
por: Yamane, Tomohiko, et al.
Publicado: (2022)

Post-treatment appearances, pitfalls, and patterns of failure in head and neck cancer on FDG PET/CT imaging
por: Purandare, Nilendu C, et al.
Publicado: (2014)

Clinical Utility of (18)F-FDG PET/CT in brachial plexopathy secondary to metastatic breast cancer
por: Chandra, Piyush, et al.
Publicado: (2016)

Basic principles and applications of (18)F-FDG-PET/CT in oral and maxillofacial imaging: A pictorial essay
por: Omami, Galal, et al.
Publicado: (2014)

Accidental diagnosis of COVID-19 pneumonia after 18F FDG PET/CT: a case series
por: Olivari, Laura, et al.
Publicado: (2020)

[(18)F]FDG-PET/CT in mechanically ventilated critically ill patients with COVID-19 ARDS and persistent inflammation
por: van Leer, Bram, et al.
Publicado: (2023)

Spectrum of brain abnormalities detected on whole body F-18 FDG PET/CT in patients undergoing evaluation for non-CNS malignancies
por: Tripathi, Madhavi, et al.
Publicado: (2011)

(68)Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact
por: Fourquet, Aloÿse, et al.
Publicado: (2020)

PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and (68)Ga‐PSMA‐11 PET Using Cyclotron‐Produced (68)Ga
por: Thompson, Scott M., et al.
Publicado: (2021)

PSMA Expression in Multinodular Thyroid Neoplasm on Simultaneous Ga-68-PSMA PET/MRI
por: Jena, Amarnath, et al.
Publicado: (2017)

Is intravenous urogram no longer an imaging of choice for percutaneous nephrolithotomy?
por: Aga, Pallavi, et al.
Publicado: (2010)

[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021)

The Modified Stenver’s View for Cochlear Implants – What do the Surgeons Want to Know?
por: McClenaghan, Fiona, et al.
Publicado: (2020)

Postoperative Imaging of Complications Following Cranial Implants
por: Ho, Chi Long, et al.
Publicado: (2019)

Multiparametric dynamic whole-body PSMA PET/CT using [(68)Ga]Ga-PSMA-11 and [(18)F]PSMA-1007
por: Dias, André H., et al.
Publicado: (2023)

Sonographic Upper Gastrointestinal Series in the Vomiting Infant: How We Do It
por: Herliczek, Thaddeus W, et al.
Publicado: (2011)

Comparison of Diagnostic Efficacy of [(68)Ga]Ga-FAPI-04 and [(18)F]FDG PET/CT for Staging and Restaging of Gastric Cancer
por: Zhang, Shumao, et al.
Publicado: (2022)

Investigation of the halo-artifact in (68)Ga-PSMA-11-PET/MRI
por: Heußer, Thorsten, et al.
Publicado: (2017)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
por: Kwan, Timothy N., et al.
Publicado: (2021)

(68)Ga-PSMA-11 PET/CT versus (68)Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis
por: Huang, Ruizhe, et al.
Publicado: (2023)

Primary Staging of Prostate Cancer Patients with [(18)F]PSMA-1007 PET/CT Compared with [(68)Ga]Ga-PSMA-11 PET/CT
por: Hoffmann, Manuela A., et al.
Publicado: (2022)

Voxel-based comparison of [(68)Ga]Ga-RM2-PET/CT and [(68)Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer
por: Fassbender, Thomas Franz, et al.
Publicado: (2020)

(68)Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma
por: de Keizer, Bart, et al.
Publicado: (2016)

(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
por: Sathekge, Mike, et al.
Publicado: (2016)

Specificity of (68)Ga-PSMA PET/CT for Prostate Cancer - Myths and Reality
por: Sasikumar, Arun
Publicado: (2017)

Letter to the Editor: (68)Ga-PSMA-11 for renal cortical PET imaging
por: Sarikaya, Ismet
Publicado: (2022)

PSMA-Positive Follicular Thyroid Carcinoma Incidentally Detected by [(68)Ga]Ga-PSMA-11 PET/CT: Correlation with Immunohistology Confirms Neovascular PSMA-Expression
por: Rosar, Florian, et al.
Publicado: (2022)

[(68)Ga]Ga-PSMA PET/MRI, histological PSMA expression and preliminary experience with [(177)Lu]Lu-PSMA therapy in relapsing high-grade glioma
por: Truckenmueller, Peter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0mlvlg3an78vj5tclokqlprm49